Biobanking-Lübeck joins BCRQUEST, BC Platforms’ Network of Biobanks

The German biobank Interdisciplinary Center for Biobanking-Lübeck (CLB-L) will join the global biobanking network. CLB-L, the first German biobank to join this network, will provide access to summary level data on 60,000 subjects with electronic health records and cohorts with genomic data. BC Platforms will provide its platform to industry R&D teams and CLB-L’s researchers to enable them to efficiently browse and analyze harmonized data for scientific research to help advance precision medicine, without compromising data security and patient confidentiality. BC Platforms is a Debiopharm Innovation Fund portfolio company.

BC Platforms’ press release